INMUNOVIROLOGIA - Prisma - Unidad de Bibliometría

INMUNOVIROLOGIA - CTS-590 (INMUNOVIROLOGIA)

Tipo de colectivo: Grupo de investigación
Estado: Grupo definitivo
Ámbito: Andalucía
Instituciones: Sistema Sanitario Público de Andalucía. Fundación Pública Andaluza para la Gestión de la Investigación en Salud de Sevilla (FISEVI)
Fecha de creación: 11/10/2007

Investiga en

Tipo Año Título Fuente
Artículo2024 Biocompatible metal-organic frameworks as promising platforms to eradicate HIV reservoirs ex vivo in people living with HIV. JOURNAL OF MATERIALS CHEMISTRY B
Artículo2024 Effect of different crosslinking agents on hybrid chitosan/collagen hydrogels for potential tissue engineering applications INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Capítulo2024 Innovación docente en bioquímica: nuevas perspectivas en el desarrollo de podcasts como una herramienta de aprendizaje en la Universidad de Sevilla Enseñanza e innovación educativa en el ámbito universitario
Artículo2024 The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers. JOURNAL OF CLINICAL INVESTIGATION
Capítulo2023 Aplicación de un ABP en carreras científicas Mejorando la enseñanza a través de la innovación educativa
Artículo2023 Hybrid polymeric Hydrogel-based biomaterials with potential applications in regenerative medicine JOURNAL OF MOLECULAR LIQUIDS
Artículo2023 Influence of Natural Crosslinkers on Chitosan Hydrogels for Potential Biomedical Applications Macromolecular Materials and Engineering
Artículo2023 Toll-like receptor agonists enhance HIV-specific T cell response mediated by plasmacytoid dendritic cells in diverse HIV-1 disease progression phenotypes EBIOMEDICINE
Artículo2023 Type-a gelatin-based hydrogel infiltration and degradation in titanium foams as a potential method for localised drug delivery. POLYMERS
Artículo2022 Anti-CD4 autoantibodies in immunological nonresponder people with HIV: cause of CD4 + T-cell depletion? AIDS
Artículo2022 Biocompatible and thermoresistant hydrogels based on collagen and chitosan POLYMERS
Artículo2022 Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response. Clinical and translational medicine
Artículo2022 Immune defects associated with lower SARS-CoV-2 BNT162b2 mRNA vaccine response in elderly people. JCI insight
Artículo2022 Single -and multi-walled carbon nanotubes as nanocarriers for the delivery of 7-hydroxyflavone. PHARMACEUTICS
Artículo2021 Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection CELLULAR & MOLECULAR IMMUNOLOGY
Artículo2019 Lower expression of plasma-derived exosome miR-21 levels in HIV-1 elite controllers with decreasing CD4 T cell count JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
Artículo2016 Immunovirological Efficacy of Once-Daily Maraviroc Plus Ritonavir-Boosted Atazanavir After 48 Weeks in Naive HIV-Infected Patients VIRAL IMMUNOLOGY
Artículo2016 Maraviroc contributes to the restoration of the homeostasis of regulatory T-cell subsets in antiretroviral-naive HIV-infected subjects CLINICAL MICROBIOLOGY AND INFECTION
Artículo2016 MicroRNA profile in CD8+T-Lymphocytes from HIV-infected individuals: relationship with antiviral immune response and disease progression PLOS ONE
Artículo2016 Monocyte Phenotype and Polyfunctionality Are Associated With Elevated Soluble Inflammatory Markers, Cytomegalovirus Infection, and Functional and Cognitive Decline in Elderly Adults JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
Artículo2016 Phenotype and Polyfunctional Deregulation Involving Interleukin 6 (IL-6)- and IL-10-Producing Monocytes in HIV-Infected Patients Receiving Combination Antiretroviral Therapy Differ From Those in Healthy Older Individuals JOURNAL OF INFECTIOUS DISEASES
Artículo2015 IFNL4 ss469415590 polymorphism is associated with unfavourable clinical and immunological status in HIV-infected individuals CLINICAL MICROBIOLOGY AND INFECTION
Artículo2015 Maraviroc Clinical Test (MCT) as an alternative tool to decide CCR5-antagonists prescription in naive HIV-infected patients ANTIVIRAL RESEARCH
Artículo2015 Structural and Functional Characterization of Anti-A33 Antibodies Reveal a Potent Cross-Species Orthopoxviruses Neutralizer PLOS PATHOGENS
Artículo2014 Maintenance of virologic efficacy and decrease in levels of beta 2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI-sparing dual therapy ANTIVIRAL RESEARCH
Artículo2014 Using a Combined Computational-Experimental Approach to Predict Antibody-Specific B Cell Epitopes STRUCTURE
Artículo2013 Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine JOURNAL OF VIROLOGY
Artículo2012 Structural and biochemical characterization of the vaccinia virus envelope protein D8 and its recognition by the antibody LA5 JOURNAL OF VIROLOGY
Artículo2011 B cell-specific expression of B7-2 is required for follicular TH cell function in response to vaccinia virus JOURNAL OF IMMUNOLOGY
Artículo2010 Combination therapy of vaccinia virus infection with human anti-H3 and anti-B5 monoclonal antibodies in a small animal model ANTIVIRAL THERAPY
Artículo2009 Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5 JOURNAL OF VIROLOGY
Artículo2009 Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement JOURNAL OF VIROLOGY
Artículo2008 NKT cells prevent chronic joint inflammation after infection with Borrelia burgdorferi PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Artículo2008 Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine JOURNAL OF VIROLOGY
Artículo2008 Selective CD4(+) T cell help for antibody responses to a large viral pathogen: Deterministic linkage of specificities IMMUNITY
Artículo2006 Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria NATURE IMMUNOLOGY
Ponencia2006 NKT cells recognize bacterial diacylglycerols JOURNAL OF IMMUNOLOGY
Artículo2005 Signaling through CD14 attenuates the inflammatory response to Borrelia burgdorferi, the agent of Lyme disease JOURNAL OF IMMUNOLOGY
Artículo1999 Characterization of membrane melatonin receptor in mouse peritoneal macrophages: Inhibition of adenylyl cyclase by a pertussis toxin-sensitive G protein JOURNAL OF NEUROIMMUNOLOGY
Artículo1998 Specific binding of melatonin by purified cell nuclei from spleen and thymus of the rat JOURNAL OF NEUROIMMUNOLOGY
Artículo1997 Differential adrenergic regulation of rat pineal cyclic AMP production and N-acetyltransferase activity during postnatal development: involvement of G(alpha S) and G(alpha i1-2) proteins JOURNAL OF ENDOCRINOLOGY
Capítulo1997 Mechanisms of action of melatonin on the human immune system: membrane versus nuclear receptors THERAPEUTIC POTENTIAL OF MELATONIN
Artículo1997 Melatonin Enhances IL-2, IL-6, and IFN-γ Production by Human Circulating CD4+ Cells: A Possible Nuclear Receptor-Mediated Mechanism Involving T Helper Type 1 Lymphocytes and Monocytes JOURNAL OF IMMUNOLOGY
Artículo1996 Binding of [I-125]iodocyanopindolol by rat harderian gland crude membranes: Kinetic characteristics and day-night variations BIOSCIENCE REPORTS
Artículo1996 Characterization of binding sites for beta-adrenergic agonists and vasoactive intestinal peptide in the rat harderian gland MICROSCOPY RESEARCH AND TECHNIQUE
Artículo1996 Specific binding of 2-[125I]iodomelatonin by rat spleen crude membranes: Day-night variations and effect of pinealectomy and continuous light exposure JOURNAL OF PINEAL RESEARCH
Artículo1995 Immunomodulatory role of melatonin - specific binding-sites in human and rodent lymphoid-cells JOURNAL OF PINEAL RESEARCH
Artículo1995 SPECIFIC BINDING OF 2-[I-125]IODOMELATONIN BY RAT SPLENOCYTES - CHARACTERIZATION AND ITS ROLE ON REGULATION OF CYCLIC-AMP PRODUCTION JOURNAL OF NEUROIMMUNOLOGY

Proyectos de Investigación

Fecha de inicio Fecha de fin Denominación Agencia financiadora Importe concedido
01/01/2022 31/05/2023 Nuevos atributos funcionales de las células T CD4 foliculares VIH especificas en el control espontáneo del VIH en individuos controladores de elite (US-1380938) Consejería de Economía, Conocimiento, Empresas y Universidad (Autonómico) 90.000,00 €
05/10/2021 31/03/2023 Encapsulating agents based on the use of metal organic frameworks as new approaching to eradicate HIV (P20_01234) Consejería de Economía, Conocimiento, Empresas y Universidad (Autonómico) 110.000,00 €
01/01/2014 31/12/2017 Predicción de la respuesta de anticuerpos altamente neutralizante y control del VIH en la colaboración de células TCD4+ (TFH) y ausencia de disfunciones de linfocitos B (PI13/01836) Ministerio de Economía y Competitividad (Instituto de Carlos III) (Nacional) 69.575,00 €

Contratos

Fecha de inicio Fecha de fin Denominación Agencia financiadora Importe concedido
30/05/2016 31/07/2017 Role of a combined antiretroviral treatment including maraviroc in the response to hepatitis B and A virus vaccine. (2808/0831) ViiV Healthcare (Desconocido)
El colectivo no tiene ningún resultado de investigación asociado